IAT

Indirect Coombs Test

Complete Blood Count

What is Indirect Coombs Test?

The indirect Coombs test, also known as the indirect antiglobulin test (IAT), detects free (unbound) antibodies circulating in the patient's serum or plasma that have the potential to bind to red blood cell (RBC) antigens. The test is performed by incubating the patient's serum with reagent red blood cells of known antigen composition. If antibodies in the serum bind to antigens on the reagent RBCs, subsequent addition of anti-human globulin (AHG) causes agglutination, indicating a positive result.

The IAT is fundamental to pretransfusion compatibility testing (crossmatching) and prenatal antibody screening. In the blood bank, it ensures that donor red blood cells are compatible with the recipient's serum before transfusion, preventing potentially fatal hemolytic transfusion reactions. In obstetrics, it screens pregnant women for clinically significant RBC alloantibodies—particularly anti-D (Rh) antibodies—that can cross the placenta and cause hemolytic disease of the fetus and newborn (HDFN). The IAT also plays a role in antibody identification panels when unexpected antibodies are detected.

Why It Matters

The indirect Coombs test is critical for safe blood transfusion and prenatal care. In transfusion medicine, a positive IAT (antibody screen) means the patient has developed alloantibodies against foreign RBC antigens, likely from prior transfusion or pregnancy. These antibodies must be identified so that antigen-negative blood can be provided, preventing hemolytic transfusion reactions. In pregnancy, detection of anti-D or other clinically significant antibodies allows monitoring and intervention (anti-D immunoglobulin, intrauterine transfusion) to prevent or manage hemolytic disease of the newborn.

Normal Reference Ranges

Group	Range	Unit
Adults and children	Negative	(no agglutination)

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High IAT Levels Mean

Common Causes

RBC alloantibodies from prior transfusion (anti-K, anti-E, anti-Fy-a, anti-Jk-a, etc.)
Anti-D antibodies in Rh-negative individuals sensitized by Rh-positive blood
Naturally occurring antibodies (anti-A, anti-B in ABO system)
Warm or cold autoantibodies reacting with screening cells
Passively acquired antibodies (anti-D immunoglobulin, IVIG)

Possible Symptoms

No direct symptoms from a positive IAT
If antibodies cause hemolysis after transfusion: fever, chills, back pain, dark urine, hypotension
In pregnancy: fetal anemia, hydrops fetalis, neonatal jaundice (due to HDFN)

What to do: A positive IAT triggers antibody identification using panels of reagent red blood cells with known antigen profiles. Once the antibody specificity is determined, antigen-negative compatible blood is selected for transfusion. In pregnancy, antibody titers are monitored serially—rising titers (typically critical titer ≥16 for anti-D) prompt referral for fetal surveillance including middle cerebral artery Doppler ultrasound. Rh-negative women receive anti-D immunoglobulin prophylaxis at 28 weeks and after delivery of an Rh-positive infant.

What Low IAT Levels Mean

Common Causes

Normal result—no clinically significant RBC antibodies detected in serum

Possible Symptoms

No symptoms associated with a negative IAT

What to do: A negative IAT means no unexpected RBC antibodies were detected, and crossmatch-compatible blood can be issued for transfusion. In pregnancy, a negative antibody screen is reassuring but should be repeated at 28 weeks gestation and after delivery. Rh-negative women with a negative screen should still receive anti-D immunoglobulin prophylaxis.

When Is IAT Testing Recommended?

Pretransfusion compatibility testing (type and screen)
Prenatal antibody screening at first visit and 28 weeks
Evaluation after suspected hemolytic transfusion reaction
Monitoring antibody titers in alloimmunized pregnancies
Prior to Rh immunoglobulin administration

Frequently Asked Questions

The indirect Coombs test ensures that you do not have antibodies in your blood that would attack the donor red blood cells. If you have previously been exposed to foreign RBC antigens through transfusion or pregnancy, your immune system may have produced alloantibodies. Transfusing incompatible blood can cause a hemolytic transfusion reaction, which can be life-threatening.

A positive indirect Coombs test during pregnancy means you have antibodies that could potentially attack your baby's red blood cells if the baby has inherited the corresponding antigen from the father. The most clinically significant is anti-D (Rh antibodies). Your doctor will monitor antibody titers and may perform fetal ultrasound surveillance. In severe cases, intrauterine transfusion may be needed.

The indirect Coombs test detects free antibodies in your serum that could bind to red blood cells in the future (used for pretransfusion testing and prenatal screening). The direct Coombs test detects antibodies already attached to your own red blood cells (used to diagnose autoimmune hemolytic anemia and transfusion reactions).

Related Biomarkers

DATDirect Coombs Test ABO/RhBlood Type (ABO & Rh)HgbHemoglobin

Want your IAT levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.